View Older Stories View More Recent Stories
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
New Report Reveals Alarming State of Software Engineering Excellence: Most Organizations Failing to Deliver on Developer Experience and DevOps Maturity
-
Form 424B2 CITIGROUP INC
-
Simon Property Group (SPG) PT Lowered to $170 at Citi
-
Tipalti Acquires AI-native Treasury Automation Provider, Statement
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Island Integrates with Ping Identity to Enable Verified Device Access
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
The Commonwealth of The Bahamas Announces Amounts Tendered as of Expiration of Cash Tender Offer for Six Series of its Notes
-
Citius Oncology (CTOR) Anticipates Commercial Launch of LYMPHIR in 2025
-
Citius Oncology Anticipates Commercial Launch of LYMPHIRâ„¢ in 2025
-
Enchanted Rock Expands Board to Guide Strategic Growth in Energy and Digital Infrastructure
-
Sanofi (SNY) Prices EUR 1.5B in Notes Offerings
-
Press release: Sanofi successfully prices €1.5 billion bond issue
-
Clearlake Capital Strengthens Team with New Senior Hires
-
Citi trims gold prices target as markets digest U.S. tariffs and geopolitics
-
Solar stocks plunge on Senate proposal to phase out tax credits by 2028
-
Form FWP Citigroup Global Markets Filed by: Citigroup Global Markets Holdings Inc.
-
Form FWP CITIGROUP INC Filed by: CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Citi Starts Protagonist Therapeutics (PTGX) at Buy
-
Citi Starts Novavax (NVAX) at Sell
-
Citi Starts NewAmsterdam Pharma Co NV (NAMS) at Buy
-
Citi sees gold below $3,000 after Q3 2025 on weak demand, growth optimism
-
Citi Starts Arcellx Inc. (ACLX) at Buy
-
Citi Starts Amylyx Pharmaceuticals inc. (AMLX) at Buy
-
Citi Starts Acumen Pharmaceuticals, Inc. (ABOS) at Buy
-
Citi Reiterates Buy Rating on Urban Outfitters, Inc. (URBN)
-
Citi Reiterates Neutral Rating on Nike (NKE)
-
McCormick & Company (MKC) PT Lowered to $77 at Citi
-
Citi Reiterates Buy Rating on MakeMyTrip (MMYT)
-
Citizens JMP Reiterates Market Outperform Rating on Zscaler (ZS)
-
Citizens JMP Reiterates Market Outperform Rating on Terns Pharmaceuticals (TERN)
-
Citizens JMP Reiterates Market Outperform Rating on Sagimet Biosciences Inc (SGMT)
-
Citizens JMP Reiterates Market Outperform Rating on Roku Inc. (ROKU)

